Nine presentations on Inflammatory Bowel Disease Prediction, Monitoring and Therapy Optimization SAN DIEGO, CA / ACCESS Newswire / May 4, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader ...

The authors of a review article on the future of ustekinumab biosimilars for treating Crohn disease (CD) discussed key ...

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study introduced a ...

Low-dose aspirin does not increase IBD flares in pregnancy, according to a study of 320 cases followed by maternal fetal ...

This new technique, called GlycoCaging, allows powerful medicines to reach the inflamed part of the gut using much lower ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

In patients with IBD on maintenance IFX, use of 5-ASA and immunomodulators does not significantly reduce flares, infections, or adverse reactions.

Black patients face higher complications related to inflammatory bowel disease than White patients, according to a study presented at DDW 2025.

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.

New Panthers wide receiver Hunter Renfrow on Thursday discussed his battle with ulcerative colitis, a chronic inflammatory ...

Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) ...

Hunter Renfrow is back in the NFL after taking last season off, and now we have a better understanding of what happened.